Diisopropylethylamine → Methyl 2-chloro-4-(5-{4-(2-methylpiperidin-1-yl)-3-[(methylsulfonyl)amino]phenyl}-1,2,4-oxadiazol-3-yl)benzoate
Reaction equation
[CH3:1][CH:2]1[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[C:8]1[CH:16]=[CH:15][C:11]([C:12]([OH:14])=O)=[CH:10][C:9]=1[NH:17][S:18]([CH3:21])(=[O:20])=[O:19].[NH2:22][C:23](=[N:35]O)[C:24]1[CH:33]=[CH:32][C:27]([C:28]([O:30][CH3:31])=[O:29])=[C:26]([Cl:34])[CH:25]=1.Cl.C(N=C=NCCCN(C)C)C.CCN(C(C)C)C(C)C>CC#N.C1COCC1>[Cl:34][C:26]1[CH:25]=[C:24]([C:23]2[N:22]=[C:12]([C:11]3[CH:15]=[CH:16][C:8]([N:3]4[CH2:4][CH2:5][CH2:6][CH2:7][CH:2]4[CH3:1])=[C:9]([NH:17][S:18]([CH3:21])(=[O:20])=[O:19])[CH:10]=3)[O:14][N:35]=2)[CH:33]=[CH:32][C:27]=1[C:28]([O:30][CH3:31])=[O:29]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
In a 2-5 microwave vial, placed in a dry-ice acetone bath, was added THF (2 mL) and CH3CN (2 mL) to a mixture of Intermediate 25 (156.19 mg; 0.50 mmol), Intermediate 34 (114.32 mg; 0.50 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (115.02 mg; 0.60 mmol). The reaction mixture was allowed to warm to RT for half a hour then DIEA (204.07 μL; 1.20 mmol) was added and the mixture was heated by microwave irradiation at 150° C. for 30 min. The reaction mixture was filtered through a SPE NH2 column (2 g) and rinsed with ACN. The filtrate was passed through a SPE SCX column (2 g) and rinsed with ACN. After evaporation of the solvents, the crude product was purified by flash chromatography (c-hex/EtOAc: 9.5/0.5), affording the title compound. LC/MS (Method B): 503.4 (M−H)−, 505.3 (M+H)+. HPLC (Method A) Rt 5.64 min (Purity: 100.0%).
Workup
- customIn a 2-5 microwave vial, placed in a dry-ice acetone bath
- temperaturethe mixture was heated by microwave irradiation at 150° C. for 30 min
- filtrationThe reaction mixture was filtered through a SPE NH2 column (2 g)
- washrinsed with ACN
- washrinsed with ACN
- customAfter evaporation of the solvents
- customthe crude product was purified by flash chromatography (c-hex/EtOAc: 9.5/0.5)
Sources & evidence
- ORD record
- ord-11a98934fbd641819b2e5047744c180a
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08202865B2
Reaction notes
Loading…